Leroy Parker is an Oncology physician affiliated with Dana-Farber Cancer Institute. OpenAlex indexes 47 publications with 4,655 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 022155418
Telephone
617-632-3427Registry record last updated 21 Nov 2011.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes
Breast Cancer Research and Treatment
2014 - Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer
International Journal of Clinical Oncology
2010 - Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine
Clinical Cancer Research
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
Toni Choueiri, MD
Dana-Farber Cancer Institute
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”